"When people say, 'Why did we move [from Washington, D.C.] to Texas?' Well, we knew that this was a great philanthropic environment. So this is really very much a Texas vaccine," although there were other, smaller donors from all over the country.
"And it's cheap, a dollar, dollar fifty a dose," Hotez says."You're not going to get less expensive than that." "The real beauty of the CORBEVAX vaccine that Drs. Hotez and Bottazzi created is that intellectual property of this vaccine will be available to everybody," Keith Martin says."So you can get manufacturers in Senegal, and South Africa and Latin America to be able to produce this particular vaccine."One drawback to the CORBEVAX technology is that it can't be modified as quickly as mRNA vaccines can to adjust to new variants.